A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to MDS
Related studies linked through entity extraction aliases.
Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Formin Gene Status and Expression in Myeloproliferative and Myelodysplastic Disorders
- Status
- COMPLETED
- Phase
- N/A
Safety Study of IL-7 in Recipients of a Hemopoietic Stem Cell Transplant Peripheral Blood Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1
Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- NA
A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status
- Status
- COMPLETED
- Phase
- PHASE1
Velcade in Myelodysplastic Syndrome - Pilot Study
- Status
- TERMINATED
- Phase
- PHASE2
Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents
- Status
- COMPLETED
- Phase
- PHASE2
Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases
- Status
- COMPLETED
- Phase
- PHASE2
Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic Transplantation From Related Haploidentical Donors
- Status
- COMPLETED
- Phase
- PHASE2
Stem Cell Transplant for Hematological Malignancy
- Status
- TERMINATED
- Phase
- NA
Stem Cell Transplantation for Hematological Malignancies
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia
- Status
- COMPLETED
- Phase
- NA